3, a domain Investment company that owns a portfolio of high value domain name assets, has sold the domain name. The sale of was first reported by Jamie Zoch in a tweet earlier this morning:

I reached out to Jason Schaeffer, an attorney who has represented in the past. He advised me that he could not comment, but did confirm the public reports that domain name was sold. I also reached out to Larry Fischer and Ari Goldberger to ask about the sale, but they were unavailable when I published this post. Based on past sales from the company, I am pretty sure the company will not publicly comment about the sale.

The current registrant of the domain name appears to be a company called Hampstead Trust. I could not find any details about the company that acquired the domain name. When I visited today, I saw a message that indicates the website will launch in the second quarter of this year. I submitted my email address to get updates about the website.

If I were to guess about the sale price, I would guess that it was a seven figure deal, possibly mid seven figures. is a great domain name, and it will be interesting to see how it will be used since medicine is such a regulated business.

About The Author: Elliot Silver is an Internet entrepreneur and publisher of Elliot is also the founder and President of Top Notch Domains, LLC, a company that has closed eight figures in deals. Please read the Terms of Use page for additional information about the publisher, website comment policy, disclosures, and conflicts of interest. Reach out to Elliot: Twitter | Facebook | LinkedIn


Leave a Reply